{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T01:04:00Z","timestamp":1773623040912,"version":"3.50.1"},"reference-count":41,"publisher":"Pleiades Publishing Ltd","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1134\/s0006297922080144","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T13:03:06Z","timestamp":1660568586000},"page":"832-838","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Regulation of SMAD Signaling Pathway by miRNAs Associated with Myocardial Fibrosis: In silico Analysis of Target Gene Networks"],"prefix":"10.1134","volume":"87","author":[{"given":"Maria","family":"Pisklova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"German","family":"Osmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Favorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"137","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"key":"2351_CR1","doi-asserted-by":"publisher","first-page":"7400","DOI":"10.2174\/0929867328666210405122703","volume":"28","author":"A. Angelopoulos","year":"2021","unstructured":"Angelopoulos, A., Oikonomou, E., Vogiatzi, G., Antonopoulos, A., Tsalamandris, S., et al. (2021) MicroRNAs as biomarkers in hypertrophic cardiomyopathy: current state of the art, Curr. Med. Chem., 28, 7400-7412, \nhttps:\/\/doi.org\/10.2174\/0929867328666210405122703.","journal-title":"Curr. Med. Chem."},{"key":"2351_CR2","first-page":"435","volume":"92","author":"A. J. Marian","year":"2001","unstructured":"Marian, A. J., Salek, L., and Lutucuta, S. (2001) Molecular genetics and pathogenesis of hypertrophic cardiomyopathy, Minerva Med., 92, 435-451.","journal-title":"Minerva Med."},{"key":"2351_CR3","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3390\/diagnostics11091720","volume":"11","author":"E. Chiti","year":"2021","unstructured":"Chiti, E., Di Paolo, M., Turillazzi, E., and Rocchi, A. (2021) MicroRNAs in hypertrophic, arrhythmogenic and dilated cardiomyopathy, Diagnostics, 11, 1720, \nhttps:\/\/doi.org\/10.3390\/diagnostics11091720.","journal-title":"Diagnostics"},{"key":"2351_CR4","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.jacc.2019.01.061","volume":"73","author":"B. J. Maron","year":"2019","unstructured":"Maron, B. J., Maron, M. S., Maron, B. A., and Loscalzo, J. (2019) Moving beyond the sarcomere to explain heterogeneity in hypertrophic cardiomyopathy: JACC review topic of the week, J. Am. Coll. Cardiol., 73, 1978-1986, \nhttps:\/\/doi.org\/10.1016\/j.jacc.2019.01.061.","journal-title":"J. Am. Coll. Cardiol."},{"key":"2351_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrg2290","volume":"9","author":"W. Filipowicz","year":"2008","unstructured":"Filipowicz, W., Bhattacharyya, S. N., and Sonenberg, N. (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?, Nat. Rev. Genet., 9, 102-114, \nhttps:\/\/doi.org\/10.1038\/nrg2290.","journal-title":"Nat. Rev. Genet."},{"key":"2351_CR6","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A. Kozomara","year":"2019","unstructured":"Kozomara, A., Birgaoanu, M., and Griffiths-Jones, S. (2019) miRBase: from microRNA sequences to function, Nucleic Acids Res., 47, D155-D162, \nhttps:\/\/doi.org\/10.1093\/nar\/gky1141.","journal-title":"Nucleic Acids Res."},{"key":"2351_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijcard.2020.11.004","volume":"327","author":"F. L. Scolari","year":"2021","unstructured":"Scolari, F. L., Faganello, L. S., Garbin, H. I., Mattos, B. P. E., and Biolo, A. (2021) A systematic review of microRNAs in patients with hypertrophic cardiomyopathy, Int. J. Cardiol., 327, 146-154, \nhttps:\/\/doi.org\/10.1016\/j.ijcard.2020.11.004.","journal-title":"Int. J. Cardiol."},{"key":"2351_CR8","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1136\/heartjnl-2013-305402","volume":"101","author":"S. P. R. Romaine","year":"2015","unstructured":"Romaine, S. P. R., Tomaszewski, M., Condorelli, G., and Samani, N. J. (2015) MicroRNAs in cardiovascular disease: an introduction for clinicians, Heart, 101, 921-928, \nhttps:\/\/doi.org\/10.1136\/heartjnl-2013-305402.","journal-title":"Heart"},{"key":"2351_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249670","volume":"21","author":"G. Osmak","year":"2020","unstructured":"Osmak, G., Kiselev, I., Baulina, N., and Favorova, O. (2020) From miRNA target gene network to miRNA function: miR-375 might regulate apoptosis and actin dynamics in the heart muscle via Rho-GTPases-dependent pathways, Int. J. Mol. Sci., 21, e9670, \nhttps:\/\/doi.org\/10.3390\/ijms21249670.","journal-title":"Int. J. Mol. Sci."},{"key":"2351_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/genes12122016","volume":"12","author":"G. Osmak","year":"2021","unstructured":"Osmak, G., Baulina, N., Kiselev, I., and Favorova, O. (2021) MiRNA-regulated pathways for hypertrophic cardiomyopathy: network-based approach to insight into pathogenesis, Genes (Basel), 12, e2016, \nhttps:\/\/doi.org\/10.3390\/genes12122016.","journal-title":"Genes (Basel)"},{"key":"2351_CR11","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1111\/j.1582-4934.2012.01523.x","volume":"16","author":"J. Wang","year":"2012","unstructured":"Wang, J., Huang, W., Xu, R., Nie, Y., Cao, X., et al. (2012) MicroRNA-24 regulates cardiac fibrosis after myocardial infarction, J. Cell. Mol. Med., 16, 2150-2160.","journal-title":"J. Cell. Mol. Med."},{"key":"2351_CR12","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/mt.2014.25","volume":"22","author":"Y. Zhang","year":"2014","unstructured":"Zhang, Y., Huang, X. R., Wei, L. H., Chung, A. C., Yu, C. M., et al. (2014) miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-\u03b2\/Smad3 signaling, Mol. Ther., 22, 974-985.","journal-title":"Mol. Ther."},{"key":"2351_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1139\/cjpp-2021-0280","volume":"100","author":"X. X. Yang","year":"2022","unstructured":"Yang, X. X., and Zhao, Z. Y. (2022) miR-30a-5p inhibits the proliferation and collagen formation of cardiac fibroblasts in diabetic cardiomyopathy, Can. J. Physiol. Pharmacol., 100, 167-175, \nhttps:\/\/doi.org\/10.1139\/cjpp-2021-0280.","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"2351_CR14","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1159\/000445568","volume":"38","author":"P. Deng","year":"2016","unstructured":"Deng, P., Chen, L., Liu, Z., Ye, P., Wang, S., et al. (2016) MicroRNA-150 inhibits the activation of cardiac fibroblasts by regulating c-Myb, Cell. Physiol. Biochem., 38, 2103-2122, \nhttps:\/\/doi.org\/10.1159\/000445568.","journal-title":"Cell. Physiol. Biochem."},{"key":"2351_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2019.143995","volume":"715","author":"X. Yang","year":"2019","unstructured":"Yang, X., Li, X., Lin, Q., and Xu, Q. (2019) Up-regulation of microRNA-203 inhibits myocardial fibrosis and oxidative stress in mice with diabetic cardiomyopathy through the inhibition of PI3K\/Akt signaling pathway via PIK3CA, Gene, 715, e143995.","journal-title":"Gene"},{"key":"2351_CR16","doi-asserted-by":"publisher","first-page":"78331","DOI":"10.18632\/oncotarget.13048","volume":"7","author":"W. S. Zhu","year":"2016","unstructured":"Zhu, W. S., Tang, C. M., Xiao, Z., Zhu, J. N., Lin, Q. X., et al. (2016) Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts, Oncotarget, 7, 78331-78342, \nhttps:\/\/doi.org\/10.18632\/oncotarget.13048.","journal-title":"Oncotarget"},{"key":"2351_CR17","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.26355\/eurrev_201808_15735","volume":"22","author":"C. C. Wang","year":"2018","unstructured":"Wang, C. C., Shang, B. B., Yang, C. W., Liu, Y. F., Li, X. D., et al. (2018) MicroRNA-325 alleviates myocardial fibrosis after myocardial infarction via downregulating GLI1, Eur. Rev. Med. Pharmacol. Sci., 22, 5339-5346, \nhttps:\/\/doi.org\/10.26355\/eurrev_201808_15735.","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"2351_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41491-9","volume":"9","author":"R. Verjans","year":"2019","unstructured":"Verjans, R., Derks, W. J. A., and Korn, K. (2019) Functional screening identifies microRNAs as multi-cellular regulators of heart failure, Sci. Rep., 9, e6055, \nhttps:\/\/doi.org\/10.1038\/s41598-019-41491-9.","journal-title":"Sci. Rep."},{"key":"2351_CR19","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.7150\/thno.20846","volume":"8","author":"H. Liang","year":"2018","unstructured":"Liang, H., Pan, Z., Zhao, X., Liu, L., Sun, J., et al. (2018) LncRNA PFL contributes to cardiac fibrosis by acting as a competing endogenous RNA of let-7d, Theranostics, 8, 1180-1194.","journal-title":"Theranostics"},{"key":"2351_CR20","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T. Thum","year":"2008","unstructured":"Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts, Nature, 456, 980-984, \nhttps:\/\/doi.org\/10.1038\/nature07511.","journal-title":"Nature"},{"key":"2351_CR21","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.cjca.2014.07.747","volume":"30","author":"S. Liu","year":"2014","unstructured":"Liu, S., Li, W., Xu, M., Huang, H., Wang, J., et al. (2014) Micro-RNA 21Targets dual specific phosphatase 8 to promote collagen synthesis in high glucose-treated primary cardiac fibroblasts, Can. J. Cardiol., 30, 1689-1699.","journal-title":"Can. J. Cardiol."},{"key":"2351_CR22","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s12265-021-10116-w","volume":"14","author":"N. Zeng","year":"2021","unstructured":"Zeng, N., Wen, Y. H., Pan, R., Yang, J., Yan, Y. M., et al. (2021) Dickkopf 3: a novel target gene of miR-25-3p in promoting fibrosis-related gene expression in myocardial fibrosis, J. Cardiovasc. Transl. Res., 14, 1051-1062, \nhttps:\/\/doi.org\/10.1007\/s12265-021-10116-w.","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"2351_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006763","volume":"6","author":"L. Li","year":"2017","unstructured":"Li, L., Bounds, K. R., Chatterjee, P., and Gupta, S. (2017) MicroRNA-130a, a potential antifibrotic target in cardiac fibrosis, J. Am. Heart Assoc., 6, e006763, \nhttps:\/\/doi.org\/10.1161\/JAHA.117.006763.","journal-title":"J. Am. Heart Assoc."},{"key":"2351_CR24","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.3892\/mmr.2020.11495","volume":"22","author":"Y. Li","year":"2020","unstructured":"Li, Y., Duan, J. Z., He, Q., and Wang, C. Q. (2020) miR\u2011155 modulates high glucose\u2011induced cardiac fibrosis via the Nrf2\/HO-1 signaling pathway, Mol. Med. Rep., 22, 4003-4016, \nhttps:\/\/doi.org\/10.3892\/mmr.2020.11495.","journal-title":"Mol. Med. Rep."},{"key":"2351_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117980","volume":"256","author":"D. Xu","year":"2020","unstructured":"Xu, D., Zhang, X., Chen, X., Yang, S., and Chen, H. (2020) Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy, Life Sci., 256, e117980, \nhttps:\/\/doi.org\/10.1016\/j.lfs.2020.117980.","journal-title":"Life Sci."},{"key":"2351_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","volume":"67","author":"J. Massagu\u00e9","year":"1998","unstructured":"Massagu\u00e9, J. (1998) TGF-beta signal transduction, Annu. Rev. Biochem., 67, 753-791, \nhttps:\/\/doi.org\/10.1146\/annurev.biochem.67.1.753.","journal-title":"Annu. Rev. Biochem."},{"key":"2351_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.588347","volume":"7","author":"S. Saadat","year":"2021","unstructured":"Saadat, S., Noureddini, M., Mahjoubin-Tehran, M., Nazemi, S., Shojaie, L., et al. (2021) Pivotal role of TGF-\u03b2\/Smad signaling in cardiac fibrosis: non-coding RNAs as effectual players, Front. Cardiovasc. Med., 7, e588347, \nhttps:\/\/doi.org\/10.3389\/fcvm.2020.588347.","journal-title":"Front. Cardiovasc. Med."},{"key":"2351_CR28","doi-asserted-by":"crossref","unstructured":"Ono, K. (2017) Translating MicroRNAs to the Clinic (Laurence, J., ed.) Academic Press, pp. 259-281.","DOI":"10.1016\/B978-0-12-800553-8.00010-X"},{"key":"2351_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.12659\/MSM.898641","volume":"23","author":"Z. Chen","year":"2017","unstructured":"Chen, Z., Lu, S., Xu, M., Liu, P., Ren, R., et al. (2017) Role of miR-24, furin, and transforming growth factor-\u03b21 signal pathway in fibrosis after cardiac infarction, Med. Sci. Monit., 23, 65-70, \nhttps:\/\/doi.org\/10.12659\/MSM.898641.","journal-title":"Med. Sci. Monit."},{"key":"2351_CR30","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.omtn.2018.04.005","volume":"11","author":"Y. Sun","year":"2018","unstructured":"Sun, Y., Wang, H., Li, Y., Liu, S., Chen, J., et al. (2018) miR-24 and miR-122 negatively regulate the transforming growth factor-\u03b2\/Smad signaling pathway in skeletal muscle fibrosis, Mol. Ther. Nucleic Acids, 11, 528-537, \nhttps:\/\/doi.org\/10.1016\/j.omtn.2018.04.005.","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2351_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004959","volume":"11","author":"L. Roy","year":"2015","unstructured":"Roy, L., Bikorimana, E., Lapid, D., Choi, H., Nguyen, T., et al. (2015) MiR-24 is required for hematopoietic differentiation of mouse embryonic stem cells, PLoS Genet., 11, e1004959, \nhttps:\/\/doi.org\/10.1371\/journal.pgen.1004959.","journal-title":"PLoS Genet."},{"key":"2351_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1182\/blood-2011-02-339911","volume":"119","author":"O. M. Pello","year":"2012","unstructured":"Pello, O. M., De Pizzol, M., Mirolo, M., Soucek, L., Zammataro, L., et al. (2012) Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology, Blood, 119, 411-421, \nhttps:\/\/doi.org\/10.1182\/blood-2011-02-339911.","journal-title":"Blood"},{"key":"2351_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-015-0047-4","volume":"4","author":"P. J. Wermuth","year":"2015","unstructured":"Wermuth, P. J., and Jimenez, S. A. (2015) The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases, Clin. Transl. Med., 4, e2, \nhttps:\/\/doi.org\/10.1186\/s40169-015-0047-4.","journal-title":"Clin. Transl. Med."},{"key":"2351_CR34","doi-asserted-by":"publisher","first-page":"6443","DOI":"10.1007\/s11033-021-06646-w","volume":"48","author":"S. M. Zhang","year":"2021","unstructured":"Zhang, S. M., Wei, C. Y., Wang, Q., Wang, L., Lu, L., et al. (2021) M2-polarized macrophages mediate wound healing by regulating connective tissue growth factor via AKT, ERK1\/2, and STAT3 signaling pathways, Mol. Biol. Rep., 48, 6443-6456, \nhttps:\/\/doi.org\/10.1007\/s11033-021-06646-w.","journal-title":"Mol. Biol. Rep."},{"key":"2351_CR35","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","volume":"44","author":"T. A. Wynn","year":"2016","unstructured":"Wynn, T. A., and Vannella, K. M. (2016) Macrophages in tissue repair, regeneration, and fibrosis, Immunity, 44, 450-462, \nhttps:\/\/doi.org\/10.1016\/j.immuni.2016.02.015.","journal-title":"Immunity"},{"key":"2351_CR36","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.bbadis.2013.06.001","volume":"1832","author":"Y. A. Nevzorova","year":"2013","unstructured":"Nevzorova, Y. A., Hu, W., Cubero, F. J., Haas, U., Freimuth, J., et al. (2013) Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis, Biochim. Biophys. Acta, 1832, 1765-1775, \nhttps:\/\/doi.org\/10.1016\/j.bbadis.2013.06.001.","journal-title":"Biochim. Biophys. Acta"},{"key":"2351_CR37","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.kint.2017.03.006","volume":"92","author":"Y. Shen","year":"2017","unstructured":"Shen, Y., Miao, N., Wang, B., Xu, J., Gan, X., et al. (2017) c-Myc promotes renal fibrosis by inducing integrin \u03b1v-mediated transforming growth factor-\u03b2 signaling, Kidney Int., 92, 888-899, \nhttps:\/\/doi.org\/10.1016\/j.kint.2017.03.006.","journal-title":"Kidney Int."},{"key":"2351_CR38","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00109-020-01879-x","volume":"98","author":"Z. Zhou","year":"2020","unstructured":"Zhou, Z., Ni, J., Li, J., Huo, C., Miao, N., et al. (2020) RIG-I aggravates interstitial fibrosis via c-Myc-mediated fibroblast activation in UUO mice, J. Mol. Med. (Berl.), 98, 527-540, \nhttps:\/\/doi.org\/10.1007\/s00109-020-01879-x.","journal-title":"J. Mol. Med. (Berl.)"},{"key":"2351_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/2040622310393059","volume":"2","author":"J. A. Wolfram","year":"2011","unstructured":"Wolfram, J. A., Lesnefsky, E. J., Hoit, B. D., Smith, M. A., and Lee, H. G. (2011) Therapeutic potential of c-Myc inhibition in the treatment of hypertrophic cardiomyopathy, Ther. Adv. Chronic Dis., 2, 133-144, \nhttps:\/\/doi.org\/10.1177\/2040622310393059.","journal-title":"Ther. Adv. Chronic Dis."},{"key":"2351_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/hrt.20.1.1","volume":"20","author":"D. Teare","year":"1958","unstructured":"Teare, D. (1958) Asymmetrical hypertrophy of the heart in young adults, Heart, 20, 1-8, \nhttps:\/\/doi.org\/10.1136\/hrt.20.1.1.","journal-title":"Heart"},{"key":"2351_CR41","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1038\/sj.emboj.7601252","volume":"25","author":"W. Zhong","year":"2006","unstructured":"Zhong, W., Mao, S., Tobis, S., Angelis, E., Jordan, M. C., et al. (2006) Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathway, EMBO J., 25, 3869-3879, \nhttps:\/\/doi.org\/10.1038\/sj.emboj.7601252.","journal-title":"EMBO J."}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297922080144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297922080144","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297922080144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:17:22Z","timestamp":1773620242000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297922080144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2351"],"URL":"https:\/\/doi.org\/10.1134\/s0006297922080144","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"3 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest in financial or any other sphere. This article does not include the experiments involving humans or animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}